BS
This company develops and supplies advanced botanical materials using proprietary plant tissue culture technology. They provide scalable and sustainable ingredients for the pharmaceutical and agricultural sectors. Their offerings include the biofungicide Quillibrium® and the vaccine adjuvant QS-21, addressing traditional supply and quality issues.
Updated 3 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- This company develops proprietary plant tissue culture technology to sustainably produce advanced botanical materials. They supply scalable, cost-effective ingredients for the pharmaceutical and agricultural sectors. Their offerings include the biofungicide Quillibrium® and the vaccine adjuvant QS-21.